23 /100
LOW RISK
Score updated Jul 13, 2026

CRI — Carter's, Inc. Dilution Risk Tracker

Track CRI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CRI — Get alerts when the score changes →

As of July 13, 2026, Carter's, Inc. (CRI) has a DilutionWatch DilutionScore of 23/100, rated LOW dilution risk. Carter's, Inc. has a market capitalization of $1.42B, 36.85M shares outstanding, 280 institutional holders tracked. Key dilution vectors include approximately 222 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CRI.
🔔 Track CRI — Get forecast alerts →

💹 Market Data

Market Cap$1.42B
Shares Outstanding36.85M
Float35.08M
Cash$473.44M
Debt$567.49M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 11.5% shares (2026Q1 vs prior)
280 institutional holders · 47.05M shares
#1 BlackRock, Inc. 5.48M shares
#2 MORGAN STANLEY 4.52M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.06M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.45M
Days to Cover3.3
% of Float9.8%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Apr 02, 2016
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CRI Shareholders

Carter's, Inc. (CRI) has a DilutionScore of 23/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for CRI shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CRI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CRI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CRI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CRI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CRI
📊 CRI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CRI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.